Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells
The Prostate, 05/17/2012
Clinical Article
Golovine KV et al. – The investigation demonstrates for the first time that piperlongumine (PL) induces rapid depletion of the androgen receptor in prostate cancer cells. As such, PL may afford novel opportunities for both prevention and treatment of prostatic malignancy.



